
A new clinical trial found that a strict low-carb diet cut liver fat by 67% in just four months, beating two popular alternative diets by a wide margin.
Story Snapshot
- Researchers at Washington University randomly assigned 55 adults with obesity, prediabetes, and fatty liver disease to one of three diets for about five months.
- The ketogenic group saw liver fat drop 67%, compared to 45% in both the Mediterranean diet group and the low-fat, plant-forward diet group.
- All three groups lost roughly the same amount of weight, about 10% of body weight, suggesting diet composition mattered beyond calories alone.
- Half the keto group no longer met criteria for prediabetes afterward, compared to 29% on the Mediterranean diet and just 7% on the low-fat diet.
What The Trial Actually Tested
The study put a real clinical problem under a microscope. Researchers recruited adults who already had obesity, prediabetes, and fatty liver disease, then split them into three groups. One followed a high-fat, low-carb ketogenic diet. Another followed a Mediterranean diet. The third ate a low-fat diet built around plant foods. Each group stuck with their plan for around five months while doctors tracked liver fat and blood sugar.
The keto group’s results stood out. Liver fat fell 67%, nearly 50% more than the 45% drop seen in both other groups. Twenty-four hour blood glucose readings told a similar story. Keto dieters saw glucose drop 20%, while the other two groups saw an 8% drop. For a population already flirting with type 2 diabetes, that gap matters.
Why Equal Weight Loss Makes This Interesting
Here’s the detail that should grab anyone who has tried dieting. All three groups lost about the same amount of weight, roughly 10% of body weight. Yet the keto group’s liver improved far more. That breaks the simple assumption that any weight loss helps the liver equally. Something about cutting carbs and ramping up fat appears to do extra work on liver tissue, independent of the scale.
The prediabetes numbers reinforce that pattern. Half the ketogenic group no longer met the clinical definition of prediabetes by the end of the trial. Compare that to 29% in the Mediterranean group and a mere 7% in the low-fat group. For readers managing blood sugar with diet alone, that is not a small difference. It is the kind of gap that changes a doctor’s recommendation.
What The Trial Doesn’t Prove Yet
No single study settles a debate this big. This trial ran about four to five months with roughly 55 participants, a modest sample for drawing sweeping conclusions. The 67% figure describes a relative drop from each person’s starting point, not proof that fatty liver disease disappeared entirely. Longer trials with bigger groups will need to confirm whether these gains hold up over a year or more, and whether they translate into fewer liver complications down the road.
Outside research backs up the general direction of these findings. A separate pilot study comparing a very low energy ketogenic diet to the Mediterranean diet also found keto produced bigger reductions in liver fat. A systematic review of five randomized trials and nine other studies likewise found ketogenic diets tend to improve liver fat and metabolic markers, while cautioning that study designs vary too much to call keto a universal fix. That caution is fair. Medical guidelines still favor Mediterranean-style eating for most patients, partly because of its stronger long-term safety record. But this trial gives doctors a specific, measured reason to consider keto for patients fighting both fatty liver and prediabetes, especially when weight loss alone isn’t moving the needle fast enough.
Sources:
sciencedaily.com, healio.com, source.washu.edu, wataugademocrat.com, ynetnews.com, ua.news, rttnews.com













